Dissecting Bottromycin Biosynthesis Using Comparative Untargeted Metabolomics
Bottromycin A2 is a structurally unique ribosomally synthesized and post‐translationally modified peptide (RiPP) that possesses potent antibacterial activity towards multidrug‐resistant bacteria. The structural novelty of bottromycin stems from its unprecedented macrocyclic amidine and rare β‐methyl...
Main Authors: | Crone, William J. K., Vior, Natalia M., Santos‐Aberturas, Javier, Schmitz, Lukas G., Leeper, Finian J., Truman, Andrew W. |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103208/ |
Similar Items
-
Structure and Biosynthesis of the Antibiotic Bottromycin D
by: Hou, Yanpeng, et al.
Published: (2012) -
Synthetic studies towards bottromycin
by: Ackermann, Stefanie, et al.
Published: (2012) -
Improved batch correction in untargeted MS-based metabolomics
by: Wehrens, Ron, et al.
Published: (2016) -
Untargeted Metabolomics To Ascertain Antibiotic Modes of Action
by: Vincent, Isabel M., et al.
Published: (2016) -
Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
by: Alonso, Arnald, et al.
Published: (2015)